Biofrontera AG to propose resolution for ordinary capital increase to the Annual General Meeting
16 avr. 2020 10h00 HE
|
Biofrontera AG
Leverkusen, Germany, April 16, 2020 (GLOBE NEWSWIRE) -- The Annual General Meeting of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) shall be held on May 28, 2020. Today, the Company...
Biofrontera Reports Full Year 2018 Financial Results
29 avr. 2019 02h00 HE
|
Biofrontera AG
Leverkusen, Germany, April 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Biofrontera AG to hold extraordinary shareholders’ meeting on 15 May 2019
26 avr. 2019 09h20 HE
|
Biofrontera AG
Leverkusen, Germany, April 26, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced in...